Company intelligence / Profile preview

Mitchell Hutchins

New York, NY, USA

Ownership: Private
Development stage: Other

Overview

Mitchell Hutchins was a distinguished American investment banking and asset management firm that played a pivotal role in the early capitalization of the biotechnology industry. Founded in 1919 and later acquired by PaineWebber in 1977, the firm was highly regarded for its institutional research and served as a lead underwriter for several landmark life sciences IPOs during the 1980s and 1990s. Through its asset management division, it operated specialized healthcare and biotechnology investment funds that provided essential growth capital to emerging drug developers. Following the acquisition of PaineWebber by UBS in 2000, the Mitchell Hutchins brand was retired and its operations were fully integrated into UBS Global Asset Management.

Industry: Investors

Beyond the preview

Go deeper on Mitchell Hutchins.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitchell Hutchins.

Explore the full profile